Streetbeat News

Products Services

NTDOY

WBD

The Nintendo Switch version of Warner Bros. Discovery Inc's (NASDAQ:WBD) Mortal Kombat 1 has faced criticism for its subpar graphics and performance issues. Ed Boon, the chief developer from NetherRealm, assured that the game will undergo significant improvements. The game's pricing, which matches that of its counterparts on more powerful consoles at $70, is also a point of contention. Actress Megan Fox, who plays Nitara in the game, has faced backlash for her voice acting.

Portfolio Pulse from Franca Quarneti

September 21, 2023 | 10:15 pm

NXU

Nxu, a US-listed company, has announced that it will open its innovative charging system to the public on September 28. This new system is expected to revolutionize the charging industry.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 10:01 pm

JAZZ

Jazz Pharmaceuticals has received approval from the European Commission for Enrylaze, a treatment for Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 9:42 pm

TSLA

Elon Musk's Neuralink, a brain-computer interface technology company, has opened up recruitment for in-human clinical trials. Musk suggested that when combined with Tesla's Optimus robot limbs, the companies could create Star Wars-like robotic limbs. The 'Luke Skywalker solution' may not be too far away, with Musk previously stating that Optimus bots would be ready to start walking around on in-house actuators by November.

Portfolio Pulse from Adam Eckert

September 21, 2023 | 9:22 pm

FLHLF

JAGX

Magdalena Biosciences, Jaguar Health (NASDAQ:JAGX) and Filament Health (OTCQB:FLHLF) have formed a joint venture to develop plant-based medicines for mental health indications. They have imported Peruvian coca leaf to Canada for research into potential treatments for adult ADHD. The coca leaves were authorized for import by the Peruvian Health Authority and will be used in Filament’s facility, Psilo Scientific, for initial research purposes.

Portfolio Pulse from Lara Goldstein

September 21, 2023 | 8:46 pm

OEC

Orion S.A. (NYSE:OEC) has opened a Battery Innovation Center in Germany to serve the growing lithium-ion battery industry. The center will accelerate Orion's product and process development. Orion will also establish a new specialized organization for its battery business, led by Dr. Adrian Steinmetz, who joins Orion from BASF. In the U.S., Orion is building a similar plant in La Porte, Texas, which will quadruple its manufacturing capacity for acetylene-based conductive additives.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 8:32 pm

FEAM

5E Advanced Materials, Inc. (NASDAQ:FEAM) has received approval from the Environmental Protection Agency (EPA) to conduct Step-Rate Testing under its existing permit. This approval is a significant step towards full boric acid and lithium carbonate extraction operations. The company aims to become the primary local U.S. provider of boron solutions and a leading global producer of boron and boron-advanced derivatives.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 8:31 pm

HE

Hawaiian Electric (HE) has restored power to more than 95% of Maui customers who lost electricity in West Maui and Upcountry since August 25.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 8:24 pm

BTCUSD

ETHUSD

The Bitcoin network has announced Alpha, a decentralized social network protocol that rivals Ethereum-based platform Friend.tech. Alpha allows users to monetize their online persona and content creation through social tokens. The protocol is anchored on the Bitcoin blockchain, with data storage on the Polygon blockchain. Trustless Computer, the project's scaling network, provides security and efficiency for deploying decentralized applications. Alpha was launched on September 16, 2023, by an independent group of Bitcoin ecosystem developers, New Bitcoin City.

Portfolio Pulse from Khyathi Dalal

September 21, 2023 | 8:12 pm

PBYI

Puma Biotechnology has secured FDA Orphan Drug Designation for Alisertib, a treatment for small cell lung cancer. This designation provides certain benefits, including tax credits for clinical testing.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 8:11 pm